The World Health Organization (WHO) has raised fresh concerns over the sustainability of immunisation gains in Africa, warning that decades of progress could be reversed due to funding cuts and rising global instability.
According to the global health body, vaccination programmes across the continent have reached more than 500 million children since 2000, preventing over four million deaths annually. In total, vaccines are estimated to have saved more than 50 million lives in Africa over the past five decades.
Despite these gains, the WHO says progress is now slowing in several countries, with emerging threats linked to geopolitical tensions, funding shortfalls and supply chain disruptions.
Health systems across the continent are increasingly under strain, particularly following a reduction in global health funding from the United States under its renewed “America First” policy. The situation has been compounded by ongoing conflict in the Middle East, which has disrupted supply chains and increased operational costs.
In 2024 alone, vaccines were credited with saving nearly two million lives across Africa, while major milestones such as the eradication of wild poliovirus in 2020 and the elimination of maternal and neonatal tetanus in most countries marked significant achievements in public health.
The WHO also highlighted progress in the fight against malaria, with vaccines now being rolled out in 25 countries. The disease continues to claim over 400,000 lives annually, most of them children under five.
“a major scientific and public health breakthrough”
Efforts to combat measles have similarly yielded results, with nearly 20 million deaths averted since 2000. Vaccination coverage has improved significantly, with 44 African countries introducing a second dose of the measles vaccine, increasing uptake from just 5% in 2000 to 55% in 2024.
In 2025, Cabo Verde, Mauritius and Seychelles became the first sub-Saharan African countries to achieve measles and rubella elimination status.
Amid these developments, Ghana has positioned itself as a leader in advancing vaccine self-sufficiency. In early 2026, Parliament established a dedicated Parliamentary Caucus on Immunisation to help mobilise domestic funding as the country prepares to transition from Gavi support by 2030.
The National Vaccine Institute is also overseeing a $75 million seed fund to support the establishment of local vaccine manufacturing capacity, as part of broader efforts to reduce reliance on external supply sources.
However, disparities in vaccine access remain a major concern. The WHO notes that a small number of countries account for the majority of children who have not received any vaccines, highlighting a widening equity gap across the continent.
“progress is uneven and in some places really slowing.”
The situation has been further exacerbated by the long-term effects of the COVID-19 pandemic, which disrupted routine immunisation programmes and increased the number of unvaccinated children.
Funding constraints continue to pose the biggest threat to immunisation efforts, with several aid-supported programmes already scaled down or discontinued, affecting access to healthcare services, personnel and critical infrastructure.
“a profound equity issue.”
Rising fuel costs linked to global conflicts have also affected vaccine distribution, particularly in areas where health facilities rely on generators for storage and cold-chain systems.
Experts warn that continued dependence on external funding is unsustainable, urging African governments to increase domestic investment in health systems to safeguard gains made over the years.
“It can’t be that we continue relying on the likes of Gavi Vaccine Alliance…”
With Africa currently off track to meet Immunisation Agenda 2030 targets, including achieving 90% vaccine coverage, the WHO is calling for urgent action to strengthen routine immunisation and ensure no child is left behind.
“Africa has made remarkable progress in less than a generation… But the progress is uneven, and even slowing…”
The organisation emphasised that while scientific breakthroughs such as malaria vaccines offer hope, the future of immunisation in Africa will depend on stronger local systems, sustained funding, and stable global supply chains.
The warning underscores the fragile balance between past public health successes and emerging global challenges, as countries across the continent work to protect vulnerable populations and secure long-term health resilience.




